Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home) (AT1Home)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Patients with type 1 diabetes have poorer glycemic control that could lead to macrovascular or neuropathic complications; in addition to an optimal treatment, prevention of diabetes complications requires to control associated risk factors, such as hypertension or dyslipidemia. Sleep apnea syndrome is a public health problem due to its high prevalence and marked morbidity and mortality, one increasingly interesting aspect is its relationship with metabolic disorders, specifically diabetes.Obstructive sleep apnea syndrome seems to be underestimated in this population. In this context, it appears to be important to estimate the prevalence of sleep respiratory diseases in patients with type 1 diabetes.
Prevalence of obstructive sleep apnea syndrome by oxymetry, confirmed by polysomnography [ Time Frame: 2 years ]
Number of patients presenting an obstructive apnea syndrome
Secondary Outcome Measures :
Relationship between sleep apnea syndrome severity and micro/macro vascular complications of type 1 diabetes [ Time Frame: 2 years ]
Number and type of micro and macro vascular complications will be analysed from medical history and new events will be collected at each visit and validated by endocrinologist
Relationship between sleep apnea syndrome severity and type 1 diabetes control [ Time Frame: 2 years ]
Results from regularly prescribed HbA1c analysis will be collected
Compliance of the Continuous Positive Airway Pressure (CPAP) after 3 months of use in patients with type 1 diabetes treated for severe SAS. [ Time Frame: 2 years ]
Objective compliance to the CPAP treatment is daily recorded into the device and will be provided by home care provider
Incidence of new cardiovascular events and changes in microangiopathic complications of diabetes patients depending on the presence of sleep apnea syndrome and to the adherence to CPAP treatment in case of sleep apnea syndrome treated [ Time Frame: 2 years ]
New events will be collected by asking the patients, after 1 year and 2 years
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Type 1 patients treated by Insulin Pump.
Male or female aged 18 to 75 years
Type 1 diabetic
Treated on insulin therapy by external pump
Take home monitoring as part of a usual care for insulin therapy by external pump
Voluntary to participate in research with written informed consent
Patient affiliated to the social security or similar regime
Privited person of liberty by judicial or administrative decision, person covered by legal protection (pregnant or lactating women, patients under guardianship) Article L1121-8
In exclusion period of other studies
Patient may, at the discretion of the investigator, not comply with the study procedures